Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$20.4 - $25.53 $177,316 - $221,906
-8,692 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$24.7 - $36.54 $15,437 - $22,837
-625 Reduced 6.71%
8,692 $218,000
Q4 2021

Mar 11, 2022

SELL
$35.83 - $45.03 $286 - $360
-8 Reduced 0.09%
9,317 $334,000
Q3 2021

Nov 10, 2021

SELL
$38.75 - $44.47 $10,966 - $12,585
-283 Reduced 2.95%
9,325 $397,000
Q4 2020

Feb 12, 2021

SELL
$32.59 - $45.26 $9,027 - $12,537
-277 Reduced 2.8%
9,608 $435,000
Q3 2020

Oct 30, 2020

SELL
$32.56 - $38.57 $9,377 - $11,108
-288 Reduced 2.83%
9,885 $350,000
Q2 2020

Aug 12, 2020

BUY
$27.83 - $37.73 $6,762 - $9,168
243 Added 2.45%
10,173 $384,000
Q1 2020

May 13, 2020

SELL
$22.38 - $54.06 $20,500 - $49,518
-916 Reduced 8.45%
9,930 $287,000
Q4 2019

Feb 12, 2020

SELL
$51.85 - $73.36 $9,903 - $14,011
-191 Reduced 1.73%
10,846 $562,000
Q3 2019

Nov 13, 2019

SELL
$40.05 - $57.47 $78,698 - $112,928
-1,965 Reduced 15.11%
11,037 $606,000
Q2 2019

Aug 14, 2019

SELL
$30.3 - $41.14 $57,994 - $78,741
-1,914 Reduced 12.83%
13,002 $528,000
Q4 2018

Feb 13, 2019

BUY
$30.16 - $43.0 $105,891 - $150,973
3,511 Added 30.78%
14,916 $501,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $42.51 $9,225 - $11,945
281 Added 2.53%
11,405 $481,000
Q2 2018

Aug 13, 2018

SELL
$28.77 - $48.27 $316 - $530
-11 Reduced 0.1%
11,124 $356,000
Q1 2018

May 14, 2018

BUY
$49.22 - $68.43 $13,289 - $18,476
270 Added 2.49%
11,135 $554,000
Q4 2017

Feb 14, 2018

SELL
$52.14 - $59.94 $9,228 - $10,609
-177 Reduced 1.6%
10,865 $586,000
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $93,571 - $106,466
1,829 Added 19.85%
11,042 $640,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,213
9,213 $455,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $247M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.